These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 3375762)
41. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: what to do if the serum creatinine and/or serum potassium concentration rises. Palmer BF Nephrol Dial Transplant; 2003 Oct; 18(10):1973-5. PubMed ID: 13679467 [No Abstract] [Full Text] [Related]
42. Angiotensin-converting-enzyme inhibitors and diuretics for hypertension. Esnault VL N Engl J Med; 2003 Jul; 349(1):90-3; author reply 90-3. PubMed ID: 12846229 [No Abstract] [Full Text] [Related]
43. [The use of angiotensin-converting enzyme inhibitors in chronic diffuse kidney diseases]. Kutyrina IM; Tareeva IE; Gerasimenko OI; Rogov VA; Miroshnichenko NG Ter Arkh; 1995; 67(5):20-3. PubMed ID: 7638769 [TBL] [Abstract][Full Text] [Related]
44. Combined blockade of the renin-angiotensin system with angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists. Azizi M; Ménard J Circulation; 2004 Jun; 109(21):2492-9. PubMed ID: 15173039 [No Abstract] [Full Text] [Related]
45. [Converting enzyme inhibitors and respiration]. Guelpa G; Vonmoos S Schweiz Rundsch Med Prax; 1989 Jan; 78(4):53-4. PubMed ID: 2645630 [No Abstract] [Full Text] [Related]
47. ACE inhibitors and ARBs: antihypertensive medications in CKD. Szromba C Nephrol Nurs J; 2005; 32(3):332-3. PubMed ID: 16035474 [No Abstract] [Full Text] [Related]
48. [Angiotensin converting enzyme inhibitors: drug of first or second choice in hypertension in advanced age]. Spławinski J; Kwolek A Kardiol Pol; 1993 Aug; 39(8):152-4, comment 155-6. PubMed ID: 8231008 [No Abstract] [Full Text] [Related]
49. [Antihypertensive therapy using a combination of angiotensin 1 receptor inhibitors with angiotensin-converting enzyme inhibitors]. Meyer GJ Dtsch Med Wochenschr; 1998 May; 123(21):681. PubMed ID: 9638097 [No Abstract] [Full Text] [Related]
52. [The therapy of arterial hypertension: a comparison between ACE inhibitors and angiotensin-II-receptor antagonists]. Rossi F; Mangrella M; Paternò E; Imperatore F; Capristo M; Imperatore C; Guarino A Clin Ter; 1996 Oct; 147(10):475-88. PubMed ID: 9264900 [TBL] [Abstract][Full Text] [Related]
53. [Renal side effects of angiotensin converting enzyme inhibitors]. Schmidt A; Mayer G Wien Med Wochenschr; 1996; 146(16):454-6. PubMed ID: 9036683 [TBL] [Abstract][Full Text] [Related]
54. Angiotensin-converting enzyme inhibitors for bevacizumab-induced hypertension. Dincer M; Altundag K Ann Pharmacother; 2006 Dec; 40(12):2278-9. PubMed ID: 17105834 [No Abstract] [Full Text] [Related]
55. ABCD of hypertension treatment. Ask about lithium, too. Smith TG BMJ; 2011 May; 342():d2718. PubMed ID: 21540270 [No Abstract] [Full Text] [Related]
57. Are more ACE inhibitors necessary? Seedat YK S Afr Med J; 1991 Sep; Suppl():7-8. PubMed ID: 1925816 [No Abstract] [Full Text] [Related]
58. Do angiotensin converting enzyme inhibitors represent a progress in hypertension care in diabetes mellitus? Sawicki PT; Mühlhauser I; Baba T; Berger M Diabetologia; 1990 Feb; 33(2):121-4. PubMed ID: 2184061 [No Abstract] [Full Text] [Related]
59. ABCD of hypertension treatment. Tell patients risk of acute kidney injury. Moonie AI BMJ; 2011 May; 342():d2717. PubMed ID: 21540269 [No Abstract] [Full Text] [Related]